FROM CORD BANK TO CORDPHARM
|
|
|
- Oliver Walsh
- 10 years ago
- Views:
Transcription
1 FROM CORD BANK TO CORDPHARM ANTHONY NOLAN CORD BLOOD PROGRAMME Expanding access Improving outcomes Opening ways
2 QuickTime and a TIFF (Uncompressed) decompressor
3 THE ANTHONY NOLAN TRUST The Anthony Nolan Research Institute University College London, England
4 THE ANTHONY NOLAN TRUST Development of the Anthony Nolan Register Anthony Nolan born suffering from Wiskott-Aldrich Syndrome Donor recruitment commenced to establish a panel of donors Anthony died without receiving a transplant Number of donor on Reg = 4000, Number of donors provided for transplant = 8020 Jan/2009
5 QuickTime and a TIFF (Uncompressed) decompressor QuickTime and a TIFF (Uncompressed) decompressor >12,000,000 donors QuickTime and a TIFF (Uncompressed) decompressor QuickTime and a TIFF (Uncompressed) decompressor QuickTime and a TIFF (Uncompressed) decompressor QuickTime and a TIFF (Uncompressed) decompressor QuickTime and a TIFF (Uncompressed) decompressor
6 ADULT MODEL: STAIR Allomandatory Jump Sibling MUD Perfect Match Adult Mismatch Quién habla de victoria.? Allotherapy Sobre ponerse es todo Rainer Maria Rilke.??
7 time a l t e r n a t i v e DRUG / AUTO THERAPY alternatives >30 W 33% 33% Diagnostic 5 W 14 W Allo Sib Allo Sib Tx 19 W 25% unfit 25% no donor UD KING S COLLEGE HOSPITAL NHS TRUST Exploratory No Donor AN Donor Overseas No Tx 21 W Survey Alloprocedures 17% 25% 34% 24% 11 W 60% 10 W Tx UD Tx 26 W 33% 14 W 42% 10 W Tx UD Tx 29 W
8 Diagnostic Allo Scoring system Urgency HLA yes CB NOD2 MUD MUD Search no CB Search CB CB Search CB Tx 11 weeks time HLA-DP mm MUD Tx >20 weeks CB Tx Objectives: DECREASING TIME INCREASING EFFECTIVENESS
9 The Large Bone Marrow Registers Name / Total donor / % ABDR typed NMDP 5,060,482 (86%) Germany 3,355,359 (63%) China Anthony Nolan 395,135 >769,372 (81%) Brazil >554,371 Israel E.M. 399,342 (70%) Italy 326,638 (67%) Japan 320,416 (100%) BBMR 310,541 (94%) Taiwan 277,936 (87%) From BMDW 23/12/08
10 Total number of HPC donations WMDA report 2007
11 Unrelated Donor Registers in the UK ANT (1974) - Anthony Nolan Trust 395,135 BBMR (1987) - British Bone Marrow Registry 310, ,974 UK donors WBMDR (1989)- Welsh Bone Marrow Donor Registry 54,298 BMDW 23/12/08
12 UK Activity new patients referred for searches 704 had their search extended internationally by end of transplants from ANT donors to patients referred from UK centres 75 transplants from BBMR donors and 22 from WBMDR donors to patients referred from UK centres 318 transplants from an international donor/cord unit to UK patients (241 adult 77 CB) 32 UK transplant centres performed at least one unrelated donor transplant (range 1-40)
13 UK Activity new patients referred for searches 857 had their search extended internationally by end of transplants from ANT donors to patients referred from UK centres 171 transplants from ANT donors to patients overseas 359 transplants from an international donor/cord unit to UK patients (265 adult 91 CB) 33 UK transplant centres performed at least one unrelated donor transplant (range 1-19)
14 Source of imported haematopoietic stem cells for UK patients in Total GERMANY USA ITALY AUSTRALIA CANADA CYPRUS FRANCE ISRAEL TAIWAN FINLAND NORWAY AUSTRIA SWITZERLAND SLOVENIA SWEDEN EIRE POLAND PORTUGAL SPAIN CHINA CORD BLOOD
15 The plan To increase the number of donations provided to UK and international patients such that 1000 patients will be treated with potential life-saving haematopoietic progenitor cells by 2013 and to increase the size of our Register to 450,000 donors
16 Donor Recruitment Predicted growth of The Anthony Nolan Trust Register Size of register No of donors deleted No of donors to be recruited Overall size of register year % increase p.a.
17 Number of donations facilitated the future No. of donations facilitated by The Anthony Nolan Trust - Future Estimates % 6% 7% 7% 7% 7% 7% est 2008 est 2009 est 2010 est 2011 est 2012 est 2013 Calendar Year
18 HLA antigens and alleles
19 Number of HLA alleles, January 2009 HLA-A HLA-B HLA-C 733(24) 1115(49) 392(9) HLA-E HLA-F HLA-G HLA-DRA HLA-DRB HLA-DQA1 HLA-DQB1 HLA-DPA1 HLA-DPB (20) (7) HLA-DMA HLA-DMB HLA-DOA HLA-DOB MICA MICB TAP1 TAP
20
21 QuickTime and a TIFF (LZW) decompressor
22
23 Low resolution HLA-A*02
24 Medium resolution HLA-A*0201/09/43N/66/78/88/89/90/91+
25 High resolution HLA-A*0201/0209
26 Allele level resolution HLA-A*
27 B Clinic Research aapc NK N Ste m Cells Co rdpharm Operations Department GIAS Cord Blood Services Adult Blood and Marrow Registry Cord Blood Bank Immunogenetics and Informatics Group ANRI Cellular Immunotherapy Group Immunogenetics ioinformatics aïve T Cells
28 Allo-option non Drug therapy yes HLA typing non Allomandatory non Drug therapy yes yes Sibling 5/6 Inclusion at AN MUD³ CBT GIAS score CBT>MUD MUD 9/10 CBT 4/6 Note: If a patient need a transplant in a defined time (urgencies), the donor available at this moment will be used
29 Scoring System: Proposal 1) Expected outcome of search: Individual frequencies Pair frequencies: DR-DQ, B-C Haplotype frequencies 2) Selection between 2-donors: Donor MUD CBT MAJOR HLA compatibility HLA compatibility CMV donor NC/CD34 dose Age donor Need for DLI MINOR Gender CMV recipient Previous pregnancies Fact accredited bank P. Blood vs BM Duration storage
30 The Anthony Nolan Cord Blood Programme Register Cell Pharmacy Cord Blood Bank Cord Blood Pharm
31 COST-BENEFIT QuickTime and a TIFF (Uncompressed) decompressor
32 BONE MARROW DONOR REGISTERS: EFFICIENCY QuickTime and a TIFF (Uncompressed) decompressor EFFICIENCY/YEAR ~ 1/1000 QuickTime and a TIFF (LZW) decompressor DONOR RATIO % QuickTime and a TIFF (LZW) decompressor RECIPIENT Cost: Inventory (150): 57,000,000, Transplant (4000): 14,250
33 QuickTime and a TIFF (Uncompressed) decompressor EFFICIENCY/YEAR ~ 1/1666 QuickTime and a TIFF (Uncompressed) decompressor Cost: Inventory(150): 679,000,000, Transplant (25,000): 27,180
34 EFFICIENCY: ~1/100 QuickTime and a TIFF (Uncompressed) decompressor Cost: Inventory (1,500): 206,000,000, Transplant: 37,784
35 Maintenance Cost UNRELATED DONOR AVAILABILITY Building phase (charitable) Cord= 50,000 ~ 75,000,000 MUD= 500,000 ~ 75,000,000 PROBABILITY e4 8&8 6&6 5&6 4&6 0 1,0E+07 1,0E+06 1,0E+05 1,0E+04 1,0E+03 1,0E+02 1,0E+01 1,0E+00 DONORS REGISTERED CB OPERON 75% 4/6 45% 5/ Maintenance phase Blood: needs 5000 ~ donors 5000/100,000 (500,000 )= cost 100 MUD: needs 3 but supply 1 ~ donors 100/100,000 (15,000 ) = cost 15,000 Cord: needs 3 ~ donors 3/100,000 (4,500 ) = cost 1, Blood Cord MUD Phase
36 Impact of cell dose and HLA Match on survival. Data presented by Dr Pablo Rubinstein at the 5 th International Umbilical Cord Blood Symposium held in Los Angeles in May Survival 5/6 Match 4/6 Match 5/6 match 4/6 match Cell Dose ( 10 7 /kg) 70% >10 50% % < <2.5 time after transplant
37 % Probability Of Patient Match Sample 2000 Patients Match 4 of Match 5 of Match 6 of Donor Sample Size
38 ANTHONY NOLAN CORD BLOOD PROGRAMME CordBank Cord Blood Bio-resource Donor Registry Cord Blood Transplantation Research Bank Stem Cell Biology Transplantation Immunology CordPharm Medicinal By-Products Cellular Stem and Immune Cells Non-Cellular RBC, Plasma, Platelets TheraCord New Therapies Haematology Adoptive Cell Therapy Non-Haematology Regenerative Medicine Tolerance
39 QuickTime and a TIFF (Uncompressed) decompressor QMP QuickTime and a TIFF (Uncompressed) decompressor Collection Storage Intelligent labeling SOP Register ID (confidentiality) RELEVANT DATA (critical steps) seal ELECTRONIC RECORDS transport ANCB FACTORY QC clinical data QuickTime and a TIFF (Uncompressed) decompressor Recep Proces Cryopres LT Storage freezer ship log Transport Directive 2004/23/EC and its technical requirements HTA FACT-NETCORD Grade C CD34/CFU IDM/ MICROBIOLOGY BLOOD TESTS QuickTime and a TIFF (Uncompressed) decompressor Clinical analysis
40 NTU Service Provider contract Building Security Maintenance Generall cleaning IT support Clean Modules Ltd Service Provider contract Maintenance COURIER Service provider Distribution KINGSCORD TPA Procurement contract SLA CB Human applications Testing Processing Storage Distribution ANCTC-NTU Cord Blood Research Research cord blood bank London LABS ANT Central Support IT H&S HRs Fundraising Marketting Operations & Registry Distribution Import/Export Financial contract contract contract Waste Company Service Provider BIOSAFE Service Provider CRYOSERVICE Service Provider Testing contract contract BD Flow Service Provider Testing BD BacTec Service Provider Other suppliers: Coulter, General Equipment, GMP-cleaning, Micronclean, others
41 Anthony Nolan Cord Blood Programme BANKING Automation Graft QualificationAN QuickTime and a TIFF (Uncompressed) decompressor COLLECTION Ethical Logistics Hospital CBB FACTORY CB RECRUITMENT AN REGISTER CB TRANSPLANT. DONOR SELECTION GIAS Search algorithm TRANSPLANTATION Gold standard: conditioning, follow-up, engraftment, chimerism Immune reconstitution KingsCord QuickTime and a TIFF (Uncompressed) decompressor CORD BLOOD BIOBANK bedside Multiple Donors: engraftment and immunotherapy Multi-donor Tx (pooling) Selection/Expansion New products: CD34/CD133, Naïve T regs, USSC/MSC, CELL THERAPY Neural ANCTC bench Associated groups Automation Data Management BIOINFORMATICS Cardiovascular Liver Basic Biology Orthopaedics
42 Cord Blood Bank 10,000 clinical units 10,000 Research cord units Cellular Immunotherapy Group CordPharm Stem cells for Tolerance induction T reg Stem cells for Cardiovascular intervention aapc for cord blood cell manipulation NK, Naive Investigating Engraftment of stem cells
43 ANCBB GIAS Wharton Club Tolerance Cord Blood Research Programme NIHR Adaptive Innate aapc Stem BMT Immuno Immunogenetics Genetics Programme BioInformatics Oxford Cardiovascular UCL Engraftment CIH ALLOSTEM 1 AND 2
44 As a SERVICE Biopharmaceutical perspective Stem cell therapy Cell lines Regenerative Medicine Health Investment Affordable commodity for a new stem cell biomedical industry
45 THE ANTHONY NOLAN TRUST Organizational Chart Mr SM Dyson Chairman Mr T Farnfield Finance & Admin. Director Mr D Knights Marketing & Comm. Director Mr G. Parkes Fundraising Director BOD Trustees Mrs H. Braund Chief Executive P. Makoni Operations Director Dr S Querol Cord Blood Bank Director Prof JA Madrigal Research & Scientific Director Research Institute Anthony Nolan Joint Scientific and Medical Advisory Committee Prof J Goldman Medical Director
46 ANTHONY NOLAN CORD BLOOD BANK (ANCBB) ANT BOD Corporate License Holder Advisory Committees (AC) ANCBB-AC Chair: Prof Madrigal ANCBB-MANAGEMENT Dr Steve McEwan, Rep License Holder Prof Goldman, Prof Madrigal, Dr Little ANT Central Services CU-AC Chair: Prof Mufti KingsCord Third Party Agreement Head-Cord Blood Services Dr Sergio Querol, Designated Individual Quality Supervisor IT Supervisor H&S Supervisor CB Provision and Transplantation Distribution KINGSCORD-MANAGEMENT KCH representative: Prof Mufti Medical Officer: Dr Dennes Operations: Katie, Winsome, Frank CB Bank & Lab Manager Anthony Nolan Cell Therapy Centre, NTU Collection Unit (CU) Supervisor Ms Terie Duffy, Person Designated Trained KCH Staff Bank Supervisor Lab Supervisor CB Bank & Lab Technicians ANT Round Table Labs Procurement Testing, Processing, Storing Organisational Chart (MSP-R-5, v3, 10/6/08)
47 Liver ANTU-NCH ccbbb: core Cord Blood bio Bank as a translational research model for cell therapy Creating a new scientific environment Heart / Neural Lung Bench ccbbb bedside Kidney Basic Science KingsCord GIAS
48 ANTHONY NOLAN CORD BLOOD BANK QuickTime and a TIFF (Uncompressed) decompressor Robert Davy, Roger Horton East Midlands Development Agency Laura Fry, Daniel Gibson, Salmah Mahmood Susana Garcia Gomez Hazel Forde, Kamal Khan, Peter Chenery Richard Duggleby, James Devitt Daniel Figueroa, Lia Zambetti, Mehri Daryouzeh Prof Tony Dodi Dr Steve Marsh, Dr Bronwen Shaw Dr Ann Margaret Little, Dr Steve McEwan Prof Robert Rees Terie Duffy, Maria Tarrio Katie Yannouzis Dr William Dennes Winsome Okeke Dr Antonio Pagliuca Prof Ghulam Mufti QuickTime and a TIFF (Uncompressed) decompressor QuickTime and a TIFF (Uncompressed) decompressor Prof John Goldman Dr Sergio Querol Prof Alejandro Madrigal Prof Nigel Russell Dr Joan Garcia QuickTime and a TIFF (Uncompressed) decompressor QuickTime and a TIFF (Uncompressed) decompressor
CORD BLOOD BANKING. Vietnam 2011. The European Group for Blood and Marrow Transplantation
CORD BLOOD BANKING Vietnam 2011 The European Group for Blood and Marrow Transplantation 1974 The Charitable Way CORD BLOOD APPROACH Today global network of public cord blood banks - 500,000 cord
Second generation of Cord Blood Banks
Second generation of Cord Blood Banks Dr Sergio Querol, Dra Marta Torrabadella, Dr Joan Garcia, Prof Alejandro Madrigal Anthony Nolan Research Institute, London & Programa Sang de Cordó, Barcelona QuickTime
Umbilical Cord Blood Transplantation
Umbilical Cord Blood Transplantation V Rocha MD, PhD Hopital Saint Louis, Paris University 7 CIBMTR Milwaukee Umbilical Cord blood transplantation Background History Clinical results in children and adults
The donor search: the best donor or cord blood unit
The donor search: the best donor or cord blood unit Dr Bronwen Shaw Consultant in haematopoietic cell transplantation Royal Marsden Hospital /Anthony Nolan Overview Where do we find donors/units for transplantation
Search Coordinator Certificate
Educational. Expert led. E learning. Information and registration Educational. Expert led. E learning. Professionals involved in unrelated adult donor/cord blood unit search and selection are essential
UMBILICAL CORD BLOOD TRANSPLANTATION: KFSH EXPERIENCE
UMBILICAL CORD BLOOD TRANSPLANTATION: KFSH EXPERIENCE HIND AL HUMAIDAN, MD,FRCPA Director, Blood Bank (Donor & Transfusion Services) and Stem Cell Cord Blood Bank Consultant Hematopathologist INTRODUCTION
CHAPTER 1 BACKGROUND AND CORD BLOOD BANK (CBB) ORGANIZATION
CHAPTER 1 BACKGROUND AND CORD BLOOD BANK (CBB) ORGANIZATION Chapter 1 BACKGROUND AND CORD BLOOD BANK (CBB) ORGANIZATION 1.1 OVERVIEW OF THE CORD BLOOD TRANSPLANTATION STUDY Bone marrow transplantation
ANTHONY NOLAN SEARCH ALGORITHM FOR A BASIC CORD BLOOD UNIT SELECTION BY SERGIO QUEROL AND IRINA EVSEEVA FEBRUARY 2012
ANTHONY NOLAN SEARCH ALGORITHM FOR A BASIC CORD BLOOD UNIT SELECTION BY SERGIO QUEROL AND IRINA EVSEEVA FEBRUARY 2012 PAGE 1 OF 7 PRINCIPLES FOR A NEW ALGORITHM Once cord blood transplantation (CBT) is
The future of unrelated Stem Cell Transplant in the UK: DOH Working Party Findings. Prof. Tony Pagliuca
The future of unrelated Stem Cell Transplant in the UK: DOH Working Party Findings Prof. Tony Pagliuca UK STEM CELL STRATEGIC FORUM The future of unrelated donor SCT in the UK Antonio Pagliuca, Transplant
Pr Eliane Gluckman, MD, FRCP, Disclosure of Interest: Nothing to Disclose
Pr Eliane Gluckman, MD, FRCP, Hospital Saint Louis, University Paris- Diderot, France Should Haplo-identical transplantation be preferred to cord blood in patients without a matched donor? Disclosure of
Directed/Related Cord Blood Collection by NHS Blood and Transplant
Directed/Related Cord Blood Collection by Jacqui Thompson Clinical Scientist Section Head of Specialist Procedures Stem Cells and Immunotherapies Department National Blood Service, NHSBT Birmingham Why
Equality of Access to Transplant for Ethnic Minority Patients Through Use of Cord Blood and Haploidentical Transplants
Equality of Access to Transplant for Ethnic Minority Patients Through Use of Cord Blood and Haploidentical Transplants Lown R.N., 1 Marsh S.G.E., 1 Blake H., 1 Evseeva I., 1 MacKinnon, S., 2 Pagliuca,
Public Cord Blood Banking at the National Cord Blood Program (NCBP)
Public Cord Blood Banking at the National Cord Blood Program (NCBP) A. Scaradavou, MD Medical Director, National Cord Blood Program, New York Blood Center Associate Attending, Pediatric BMT Memorial Sloan-Kettering
Topics in Regenerative Medicine Kings College London 21/01/2011
CORD BLOOD BANKING OPTIMISING INVENTORIES PUBLIC vs PRIVATE Anthony Nolan Cell Therapy Centre Dr. Susana G Gomez CORD BLOOD APPROACH The first cord blood transplant was performed on a 5 year-old Parisian
A fact sheet UNRELATED BONE MARROW AND CORD BLOOD STEM CELL TRANSPLANTS
A fact sheet UNRELATED BONE MARROW AND CORD BLOOD STEM CELL TRANSPLANTS Each year, thousands of patients are diagnosed with diseases treatable by a blood stem cell transplant. These blood stem cells can
Corporate Medical Policy Cord Blood as a Source of Stem Cells
Corporate Medical Policy Cord Blood as a Source of Stem Cells File Name: Origination: Last CAP Review: Next CAP Review: Last Review cord_blood_as_a_source_of_stem_cells 2/2001 3/2015 3/2016 3/2015 Description
Annual Report 2006. The Norwegian Bone Marrow Donor Registry
Annual Report The Norwegian Bone Marrow Donor Registry ANNUAL REPORT THE NORWEGIAN BONE MARROW DONOR REGISTRY The Norwegian Bone Marrow Donor Registry (NBMDR) was established in 199 at the Institute of
Cord Blood for Cellular Therapy: A Snapshot of this Evolving Market Landscape
GENReports: Market & Tech Analysis Cord Blood for Cellular Therapy: A Snapshot of this Evolving Market Landscape > Enal Razvi, Ph.D. Biotechnology Analyst, Managing Director SELECTBIO US [email protected]
Do you have anything to add? If so, I d love to hear from you! Jessica Robinson Conference Manager Life Sciences @jessbiopharma
1 Who is the most influential figure in cord blood around the world? What is the biggest challenge to overcome in the use of cord blood as a source of stem cells? We asked 10 leading experts in the cord
New Zealand Bone Marrow Donor Registry
Title: Authorised by: SECTION 9.0 NZBMDR STANDARDS PROCESS FOR AN UNRELATED STEM CELL DONOR WORKUP & IDENTIFICATION OF CORD BLOOD UNITS Executive Officer Contributing Authors: Sally Gordon Dr Hilary Blacklock
Cord blood stem cells for hematopoietic stem cell transplantation in the UK: how big should the bank be?
Original Article Cord blood stem cells for hematopoietic stem cell transplantation in the UK: how big should the bank be? Sergio Querol 1,2,3 Ghulam J. Mufti, 3 Steven G.E. Marsh, 1,2 Antonio Pagliuca,
PACT Web Seminar July 19, 2007
PACT Web Seminar July 19, 2007 Phyllis I. Warkentin, MD Professor, Pathology and Pediatrics University of NE Medical Center Medical Director Chairman, Accreditation Program Foundation for the Accreditation
Using Cost Effectiveness Analysis to Determine Inventory Size for a National Umbilical Cord Blood Bank
Using Cost Effectiveness Analysis to Determine Inventory Size for a National Umbilical Cord Blood Bank Martin Maiers, Bioinformatics National Marrow Donor Program, USA NMDP Minneapolis, MN, USA NATIONAL
Laura Machin, Lancaster Medical School, UK Takuya Matsushige, National Institute of Public Health, Japan Richard Williams, Management Science,
Laura Machin, Lancaster Medical School, UK Takuya Matsushige, National Institute of Public Health, Japan Richard Williams, Management Science, Lancaster University, UK Today Exploring Perceptions of 'Quality'
How to select a donor and product for allogeneic HCT
How to select a donor and product for allogeneic HCT Dr Bronwen Shaw 10 February 2015 Overview Who (and where) are the donors What factors determine how we choose between them Acquisition Clinical Donor
EUROCORD. in 49 countries and 484 transplant centres* 264 EBMT 4847 (73%) cases 220 Non-EBMT 1797 (27%) cases
! 21%! EUROCORD 6756 cord blood transplantations performed from 1988 to March 2010 in 49 countries and 484 transplant centres* 264 EBMT 4847 (73%) cases 220 Non-EBMT 1797 (27%) cases * missing center
The Danish Bone Marrow Donor Registry DBMDR
The DBMDR Vision To achieve and maintain a position as an internationally recognized hematopoietic stem cell donor registry with respect to high quality of donor data base and HLA typing, individualized,
Pros and Cons of Stem Cell Sources and their availability in Africa. Dr Jaimendra Singh Inkosi Albert Luthuli Central Hospital Durban, South Africa
Pros and Cons of Stem Cell Sources and their availability in Africa Dr Jaimendra Singh Inkosi Albert Luthuli Central Hospital Durban, South Africa Introduction The ability to perform a haematopoietic stem
5. All cord blood banks should be subject to the same standards, regulations and accreditation requirements.
WMDA Policy Statement for the Utility of Autologous or Family Cord Blood Unit Storage (This policy statement has been approved and adopted by the WMDA board on the 25 th of May 2006) The Cord Blood Registries
A Cure for Sickle Cell Anemia and Thalassemia
IV Simpósio Internacional de Hemoglobinopatias A Cure for Sickle Cell Anemia and Thalassemia Bertram Lubin, MD and Mark Walters, MD 4 September 2007 Topics to be covered Cord blood: Importance and biology
Cord blood banking: information for parents
Cord blood banking: information for parents Published August 2006 by the RCOG Contents Page number Key points 1 About this information 2 What is cord blood? 2 Why is cord blood useful? 3 How is cord blood
SAVE A LIFE... BY GIVING LIFE!
SAVE A LIFE... BY GIVING LIFE! FOLLOW US ON: HÉMA-QUÉBEC PUBLIC CORD BLOOD BANK www.hema-quebec.qc.ca Scan this code with your smart phone to access the page Register to the Public Cord Blood Bank on the
Reference: NHS England B04/P/a
Clinical Commissioning Policy: Haematopoietic Stem Cell Transplantation (HSCT) (All Ages): Revised Reference: NHS England B04/P/a 1 NHS England Clinical Commissioning Policy: Haematopoietic Stem Cell Transplantation
Corporate Medical Policy Cord Blood as a Source of Stem Cells
Corporate Medical Policy Cord Blood as a Source of Stem Cells File Name: Origination: Last CAP Review: Next CAP Review: Last Review cord_blood_as_a_source_of_stem_cells 2/2001 3/2015 3/2016 3/2015 Description
4. All cord blood banks should be subject to the same standards, regulations and accreditation requirements.
WMDA Policy Statement on the Utility of Autologous or Family Cord Blood Unit Storage The WMDA Board adopted this policy on 25 th of May 2006. Policy updated _April 2011 The Cord Blood Working Group and
Cord Blood Bank Business Plan
Cord Blood Bank Business Plan A sample of how to create a new program Produced by the AABB subsection: Cellular Therapy Business Management with major contributions by Nicole Omer TABLE OF CONTENTS Page
Support Program for Improving Graduate School Education Advanced Education Program for Integrated Clinical, Basic and Social Medicine
Support Program for Improving Graduate School Education Advanced Education Program for Integrated Clinical, Basic and Social Medicine January 27, 2009 Dear Professors (representative) of departments, Subject:
A Public Cord Blood Bank for South Africa? i
No. 42/2007 A Public Cord Blood Bank for South Africa? i By Dr Robert Crookes MBChB (Wits), Dip. Internal Medicine (American Board of Internal Medicine, USA) Transfusion Medicine Consultant. South African
SEARCHING FOR A BONE MARROW DONOR
SEARCHING FOR A BONE MARROW DONOR Angela received a bone marrow transplant from an unrelated donor to treat her non-hodgkin s lymphoma. INFORMATION FOR PATIENTS AND THEIR FAMILIES For patients who need
Part 1 Findings and Recommendations
The Future of Unrelated Donor Stem Cell Transplantation in the UK Part 1 Findings and Recommendations A Report from the UK Stem Cell Strategic Forum July 2010 www.nhsbt.nhs.uk Foreword Haemopoietic stem
hematopoietic stem cells from cord blood: - costless but too expensive? Dr. Vincent Kindler Geneva Cord Blood Bank HUG vincent.kindler@hcuge.
hematopoietic stem cells from cord blood: - costless but too expensive? Dr. Vincent Kindler Geneva Cord Blood Bank HUG [email protected] Spring water: Manufactured by nature COSTLESS Cord Blood:
UMBILICAL CORD BLOOD, STEM CELL BANKING
UMBILICAL CORD BLOOD, STEM CELL BANKING Dr.Sharad Jain MD Blood Transfusion officer, & I/C Transfusion Medicine NSCB Medical College. Jabalpur.MP. Introduction: Every parent during childbirth DREAMS the
Cord Blood: that other stem cell source. Donna Wall, MD Director, Manitoba Blood and Marrow Transplant Program
Cord Blood: that other stem cell source Donna Wall, MD Director, Manitoba Blood and Marrow Transplant Program CBMTG April 2012 The problem: In order to perform a BMT from one person to another one needs
Bone Marrow, Peripheral Blood Stem Cells or Umbilical Cord Blood transplantation? Federica Giannotti, MD Eurocord-Hôpital Saint Louis, Paris
Bone Marrow, Peripheral Blood Stem Cells or Umbilical Cord Blood transplantation? Federica Giannotti, MD Eurocord-Hôpital Saint Louis, Paris Background Hematopoietic stem cell transplantation (HSCT) is
Outcome of Unrelated HSCT in Patients Lacking HLA Matched Related Donors: Iranian Stem Cell Donor Program (ISCDP)
Outcome of Unrelated HSCT in Patients Lacking HLA Matched Related Donors: Iranian Stem Cell Donor Program (ISCDP) October 18, 2014 19th Congress of APBMT, Hangzhou, China AMIR ALI HAMIDIEH, MD Iranian
How To Understand The Science Of Cord Blood
The Future of Unrelated Donor Stem Cell Transplantation in the UK Part 2 Annexes A Report from the UK Stem Cell Strategic Forum July 2010 www.nhsbt.nhs.uk Table of Contents Abbreviations... 6 Glossary...
Stem Cell Transplantation and the Canadian First Nations Community. Becky Luk (PTLS) Tanya Petraszko, MD
Stem Cell Transplantation and the Canadian First Nations Community Becky Luk (PTLS) Tanya Petraszko, MD Why is there a need for stem cells? Our Story Why are we engaging the First Nations, Metis and Inuit
International NetCord Foundation Executive Committee Conference Call Minutes September 10, 2014
International NetCord Foundation Executive Committee Conference Call Minutes September 10, 2014 Committee Members: Staff: President Etienne Baudoux and Drs. Gesine Koegler, Joanne Kurtzberg and Alexander
The Infinite Potential of Stem Cell Japan s Cord Blood Bank and Transplant
The Infinite Potential of Stem Cell Japan s Cord Blood Bank and Transplant Speech by Dr. Tsuneo A. Takahashi Translated by Stella Wang Japan and the United States are the two most experienced countries
Cord Blood Market Trends, circa 2014
GENReports: Market & Tech Analysis Cord Blood Market Trends, circa 2014 > Enal Razvi, Ph.D. Managing Director Select Biosciences, Inc. [email protected] Topic Introduction and Scope The focus of this GEN
So, get comfortable and enjoy finding out what the greatest achievements and challenges are facing the industry today.
1 Who is the most influential figure in cord blood around the world? What do you think has been the biggest achievement within the cord blood sector? Which is the most important development in cord blood
Cord Blood Bank Technology. E. Baudoux M. Duffy S. Querol L. Foeken. Survey Introduction
Cord Blood Bank Technology E. Baudoux M. Duffy S. Querol L. Foeken Survey Introduction Preliminary considerations CB comparable to BM (Children) CB comparable to BM (Adults) Haplo identical transplants
NEWS RELEASE. For Immediate Release. For more information, please contact:
NEWS RELEASE For Immediate Release For more information, please contact: Charlene Han Singapore Cord Blood Bank Tel: (65) 6394-5017 [email protected] Singapore Cord Blood Bank records 21 st
A Gift for life. HTA Licence No. 22653
A Gift for life HTA Licence No. 22653 2 3 the best possible gift for your new born child. 4 6 8 9 10 12 14 16 19 what is cord blood current treatments services contents properties for treatment process
How To Be A Good Donor
1 of 26 pages World Marrow Donor Association International Standards for Unrelated Hematopoietic Progenitor Cell Donor Registries Document Type: Standards WG/Committee: STDC World Document Reference: 20140101-STDC-
Hematopoietic Stem Cell Transplantation. Imad A. Tabbara, M.D. Professor of Medicine
Hematopoietic Stem Cell Transplantation Imad A. Tabbara, M.D. Professor of Medicine Hematopoietic Stem Cells Harvested from blood, bone marrow, umbilical cord blood Positive selection of CD34 (+) cells
CORD BLOOD TRANSPLANTATION STUDY EXPANDED ACCESS PROTOCOL APPENDIX A SAMPLE CONSENT FORM
APPENDIX A SAMPLE CONSENT FORM CORD BLOOD TRANSPLANTATION (COBLT) STUDY SAMPLE CONSENT FORM FOR THE EXPANDED ACCESS PROTOCOL You (your child) are being asked to take part in a clinical research study.
Recommendations to Transplant Centres Performing Cord Blood Transplants. Why Choosing the Right Thaw Method Could Save a Patient s Life
Recommendations to Transplant Centres Performing Cord Blood Transplants Vicki Antonenas Why Choosing the Right Thaw Method Could Save a Patient s Life Lynn O Donnell (USA) 1 The process of receiving, testing
Asian Harmonization via Cord Blood Bank Network
Asian Harmonization via Cord Blood Bank Network Introduced by Shigetaka Asano Of Tokyo Cord Blood Bank SCA 200, Seoul Country China Indonesia Philippines Vietnam Japan Thailand Myanmar Korea Malaysia Cambodia
Transmedcon 2014. Ahmedabad, Gujarat November 14-16, 2014
FACT Accreditation for Cord Blood Banks and Cellular Therapy Nadim Mahmud, MD, PhD Associate Professor of Medicine Division of Hematology/Oncology Director, Hospital Stem Cell Laboratory Blood & Marrow
Beyond Cell Dose: Selection of the Optimal Umbilical Cord Blood Unit. Karen Ballen, MD Massachusetts General Hospital June, 2012
Beyond Cell Dose: Selection of the Optimal Umbilical Cord Blood Unit Karen Ballen, MD Massachusetts General Hospital June, 2012 OUTLINE Cell Dose HLA Typing HLA C and KIR HLA Antibodies ABO and Racial/Ethnic
Overview of OneMatch, including the OneMatch Public Cord Blood Bank
Overview of OneMatch, including the OneMatch Public Cord Blood Bank Dr. Heidi Elmoazzen, Director OneMatch Public Cord Bank 2012-09-27 Outline Overview and Introduction Overview of the need for stem cells
Le norme internazionali NetCord-FACT: linee guida per la qualità nel bancaggio del sangue cordonale
Le norme internazionali NetCord-FACT: linee guida per la qualità nel bancaggio del sangue cordonale Topics 1- NetCord-FACT: l organizzazione internazionale ed il suo scopo 2- Le norme di qualità sul bancaggio
An Introduction to Canada s National Public Cord Blood Bank
An Introduction to Canada s National Public Cord Blood Bank Dr. Heidi Elmoazzen Director, National Public Cord Blood Bank Hematopoetic Stem Cells Hematopoetic stem cells are not yet mature (undifferentiated)
THE INFLUENCE OF TISSUE (IN)COMPATIBILITY IN UMBILICAL CORD BLOOD TRANSPLANTATION
THE INFLUENCE OF TISSUE (IN)COMPATIBILITY IN UMBILICAL CORD BLOOD TRANSPLANTATION Matjaž Jeras Blood Transfusion Centre of Slovenia Tissue Typing Center Šlajmerjeva 6, 1000 Ljubljana, Slovenia [email protected]
Program Co-Chairmen: Dr. John Wagner, University of Minnesota Dr. Richard Champlin, M.D. Anderson Cancer Center
(last updated May 13, 2004) This is an activity offered by CBBS, a CMA accredited provider. Physicians attending this course may report up to 13.25 hours of Category 1 credits toward the California Medical
Flow cytometric analysis of stem cells derived from umbilical cord blood CD34+/CD45+ enumeration and viability
Flow cytometric analysis of stem cells derived from umbilical cord blood CD34+/CD45+ enumeration and viability Doretha Thompson Dissertation in fulfillment of the requirements for the degree Magister Scientiae
Helping you find the one match.. Guide for Unrelated Stem Cell Transplant Patients OneMatch Stem Cell and Marrow Network BLOOD.
Helping you find the one match.. Guide for Unrelated Stem Cell Transplant Patients OneMatch Stem Cell and Marrow Network BLOOD.CA WWW This guide is intended for patients in need of an unrelated volunteer
Stem cells and motor neurone disease
Stem cells and motor neurone disease F Stem cell research has fuelled hope of a treatment for a variety of conditions. This information sheet explains what these cells are and includes details of the current
Umbilical Cord Blood Stem Cells Current Status & Future Potential
Umbilical Cord Blood Stem Cells Current Status & Future Potential Natasha Ali Assistant Professor Haematology Department of Pathology & Laboratory Medicine/Oncology The Aga Khan University Email: [email protected]
cord blood saves lives...
cord blood saves lives... ...by providing a rich source of blood stem cells that can be used to treat over 80 different diseases including leukemia, lymphoma, thalassemia, Tay-Sachs and sickle cell anemia.
Narrator: Transplants using stem cells from the blood, bone marrow or umbilical cord blood
[Track 2: What Is a Transplant?] Narrator: Transplants using stem cells from the blood, bone marrow or umbilical cord blood can be an effective treatment for people with blood cancers such as leukemia,
European Research Council
ERC Starting Grant Outcome: Indicative statistics Reproduction is authorised provided the source ERC is acknowledged ERCEA/JH. ERC Starting Grant: call Submitted and selected proposals by domain Submitted
Unrelated Donor Stem Cell Transplantation in the UK
Unrelated Donor Stem Cell Transplantation in the UK Effective Affordable Sustainable A Report from the UK Stem Cell Strategy Oversight Committee November 2014 www.nhsbt.nhs.uk Contents Introduction 3
Faculty. Coordinators. Teachers III. Transfusion Medicine Dept., Ospedale Civile di Pescara, Pescara, Italy
Faculty Coordinators IACONE Antonio GARCÍA Joan WERNET Peter BONFINI Tiziana REBULLA Paolo Advanced Therapy Division, Banc de Sang i Teixits; Associate Chair of Transfusion Medicine and Cell and Tissue
CORD BLOOD BANKING FAQ
CORD BLOOD BANKING FAQ Cord Blood & Stem Cells Q: What is umbilical cord blood (UCB)? A: Bone marrow, peripheral blood and UCB constitute the three primary sources of stem cells. Cord blood, which, until
AUTOMATION OF THE COLONY-FORMING CELL ASSAY FOR MEASURING HEMATOPOIETIC PROGENITORS IN CORD BLOOD
AUTOMATION OF THE COLONY-FORMING CELL ASSAY FOR MEASURING HEMATOPOIETIC PROGENITORS IN CORD BLOOD Bert Wognum Oliver Egeler Caren Grande Ning Yuan Steven Woodside Terry Thomas Allen Eaves STEMCELL Technologies
OUR JOURNEY THROUGH THE YEARS
The King Faisal Specialist Hospital and Research Centre Experience in Hematology, Oncology and Bone Marrow Transplantation OUR JOURNEY THROUGH THE YEARS REGGIE BELKHEDIM A Brief Overview: King Faisal Specialist
How To Run A Cord Blood Bank
INTERNATIONAL STANDARDS FOR CORD BLOOD COLLECTION, BANKING, AND RELEASE FOR ADMINISTRATION ACCREDITATION MANUAL Fifth Edition DRAFT September 2012 NOTICE These Standards are designed to provide minimum
UMBILICAL CORD BLOOD BANKING A guide for parents
UMBILICAL CORD BLOOD BANKING A guide for parents 2 nd EDITION INTRODUCTION The cells contained in the umbilical cord blood have therapeutic value for the treatment of blood disorders and immune diseases.
